Clinical Trial Update: The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the effect of Upneeq (oxymetazoline hydrochloride 0.1%) on eyelid position, redness, and appearance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctival Inflammation
• Eye Manifestations
• Ptosis

Drugs mentioned

• Upneeq (oxymetazoline)

Snippet

Sponsor: University of Miami | Conditions: Ptosis, Eyelid, Conjunctiva Inflamed | Phase 4 | Status: COMPLETED | Results posted: 2023-04-24